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A B S T R A C T
This prospective, open label, uncontrolled study was performed to evaluate the efﬁcacy and tolerability
of themodiﬁed Atkins diet in childrenwith refractory infantile spasms. Fifteen consecutive children aged
six months to three years having daily infantile spasms in clusters with electroencephalographic
evidence of hypsarrhythmia despite treatment with hormonal treatment (oral corticosteroids/
adrenocorticotrophic hormone) and/or vigabatrin, and at least one additional anti-epileptic drug were
enrolled. Children with known or suspected inborn errors of metabolism or systemic illnesses were
excluded. Carbohydrate intake was restricted to ten grams/day. Among these 12 boys and three girls
(median age-24 months), 13 had symptomatic etiology. After three months of diet, six children were
spasm free. The time to spasm freedom after diet initiation ranged from two days to two months. The
most frequent adverse effect observed was constipation. The modiﬁed Atkins diet was found to be
effective and well tolerated in children with refractory infantile spasms (ClinicalTrials.gov identiﬁer:
1 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.1. Introduction
Infantile spasms comprise an infantile epileptic encephalopa-
thy characterized by hypsarrhythmia on EEG, and frequent
neurodevelopmental regression.1 Unfortunately the treatment of
this disorder remains difﬁcult. The ﬁrst-line options which include
hormonal therapy, i.e., adrenocorticotropic hormone (ACTH) or
oral corticosteroids, and vigabatrin are effective in 60–70% of the
patients. These are however associated with signiﬁcant side
effects, and high relapse rates. Newer drugs such as topiramate,
zonisamide, and levetiracetam have also been evaluated; however
these drugs are less effective than ACTH.2,3 The ketogenic diet (KD)
is a medically supervised high fat, low carbohydrate diet, which
has been used for the treatment of intractable childhood epilepsy.4
The KD has also been shown to be effective for intractable infantile
spasms; often after ACTH and vigabatrin have failed.5–10 However,
the traditional KD has its drawbacks. It restricts calories and
NCT01006811).
 201Abbreviations: ACTH, Adrenocorticotropic hormone; EEG, Electroencephalography;
KD, Ketogenic diet; CI, Conﬁdence intervals.
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doi:10.1016/j.seizure.2011.08.009proteins, and requires weighing of foods. Hospitalization is
generally advocated for diet initiation. Furthermore, growth
problems have also been reported in children on KD secondary
to protein restriction.
The modiﬁed Atkins diet is a less restrictive alternative to the
KD.11 This diet can be started on an outpatient basiswithout fasting.
It allows unlimited intake of proteins and fats, and does not restrict
calories or ﬂuids. Studies of this diet have demonstrated its efﬁcacy
and safety in refractory childhood epilepsy.12–16 However, there are
no published reports on the use of this diet in infantile spasms.
Hence this study was conducted with an objective to evaluate the
feasibility, efﬁcacy and tolerability of the modiﬁed Atkins diet in
children with infantile spasms refractory to ﬁrst-line treatment.
2. Methods
This prospective open label, uncontrolled, study was conducted
in the Pediatric department of All India Institute of Medical
Sciences, New Delhi, between October 2009 and October 2010.
Ethical approval was obtained from the institutional ethics
committee. The trial was registered in the clinicaltrials.gov registry
(ClinicalTrials.gov identiﬁer: NCT01006811). Written informed
consent was obtained from the parents prior to enrolment.
2.1. Participants
Children aged six months to three years with daily infantile
spasms in clusters, persisting for more than 6 weeks, at least onevier Ltd. All rights reserved.
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rhythmia or its variants and failure of hormonal treatment (oral
corticosteroids/adrenocorticotrophic hormone) and/or vigabatrin,
and at least one more anti-epileptic drug were enrolled. Children
with known or suspected inborn errors of metabolism as
evidenced by: 2 or more of the following: a history of parental
consanguinity, prior affected siblings, unexplained vomiting,
intermittent worsening of symptoms, recurrent episodes of
lethargy, altered sensorium, or ataxia, hepatosplenomegaly on
examination And/or 2 or more of the following biochemical
abnormalities high blood ammonia (>80 mmol/L), high arterial
lactate (>2 mmol/L), metabolic acidosis (pH <7.2), hypoglycaemia
(blood sugar <40 mg/dl), abnormal urinary aminoacidogram,
presence of reducing sugars or ketones in urine, and positive
results on urine neurometabolic screening were excluded.
Children from families with motivational issues likely to affect
compliance and those with systemic illness were also excluded.
Because of the exploratory nature of this trial, we planned a
convenience sample of 15 consecutive patients.
2.2. Pre-diet preparation
During a two week period, baseline clinical evaluation was
done. Parents were educated to note the frequency of clusters and
spasms and maintain seizure logs. Medications were changed to
carbohydrate free preparations. ACTH or corticosteroids were
tapered off two weeks before starting the diet.
2.3. Modiﬁed Atkins diet administration
Carbohydrate intake was restricted to 10 g/day. Carbohydrate
content of various food items was explained to the parents, and
exchange lists were provided. Fat intake (e.g. cream, butter, oils,
ghee) was actively encouraged and protein intake was not
restricted. A list of recipes based on common locally available
foods was provided. For the younger infants not started on semi-
solid food, a liquid diet based on milk, soya-milk, cream and oil
was explained, Each child also received a sugar-free, fat soluble
vitamin supplement and calcium supplementation. The antiepi-
leptic drugs were continued unchanged during the three month
study period. Parents were asked to check urine ketones by
reagent sticks daily for the ﬁrst week on the diet and twice weekly
thereafter.
2.4. Follow up
Follow up was scheduled for two weeks, one, two and three
months after diet initiation. Weight and urine ketones by reagent
strips were checked at each visit. For children found to have nil or
trace ketones, the child’s diet records were reviewed with the
family. If the need arose the family was re-explained the diet.
Spasm frequency was checked according to parental reports and
seizure logs. A sleep and a short awake EEG record was repeated in
those who were seizure free or had a change in seizure type. The
primary outcome measure was the proportion of children with
spasm freedom for at least 15 days, three months after diet
initiation. All adverse events during the diet were noted as per
parental reports. The following investigations were obtained at
baseline: electroencephalography (EEG), blood urea, serum
creatinine, liver function tests (serum bilirubin, serum glutamate
oxaloacetate transaminase [SGOT], serum glutamate pyruvate
transaminase [SGPT] and serum albumin), fasting lipid proﬁle
including total cholesterol, serum triglycerides, low density
lipoprotein [LDL], high density lipoprotein [HDL], and very low
density lipoprotein [VLDL]. The biochemical proﬁle was repeated
at six months in those patients continuing the diet.3. Results
Nineteen children met the inclusion criteria. Four were
excluded from the trial; three because of motivational issues in
family and one because of suspected inborn error of metabolism.
Of the ﬁfteen children enrolled for the study, 12 were boys. In two
children, spasms were cryptogenic, and in the rest they were
symptomatic. Perinatal brain injury was present in 8 of the 13
children with symptomatic etiology (Table 1). All the children had
co-morbid global developmental delay, while 13 had cerebral
palsy. ACTH had been tried in 11 patients, oral prednisolone in 5
patients, and vigabatrin in 12 patients. Nine patients had failed
trial of both ACTH and vigabatrin. Other drugs which had been
tried included topiramate, sodium valproate, levetiracetam,
zonisamide and benzodiazepines.
At three months after starting the diet, six patients (40%) were
free of spasms. The median time from the initiation of diet to the
last witnessed spasm was six days (range 2–60 days). There was
electroencephalographic resolution of hypsarrhythmia in all these
children. None of these children developed other seizure types. In
one child spasms subsided but myoclonic jerks (2–3/week)
continued. His EEG showed resolution of hypsarrhythmia but
persistent multifocal interictal epileptiform discharges. Addition-
ally, three children had a more than 50% reductions in spasm
clusters. Four patients had no response at all, and the diet was
discontinued at one month in two of these children, and at six
weeks and two months in one child each. At six months follow up,
nine patients were still on the diet. Out of these, six were spasm
free, and three hadmore than 90% reduction in spasms. In addition
to spasm freedom, parents have also reported improved alertness
and interaction in all diet responsive children.
Constipation was the most frequent side effect, seen in six
children. Four children experienced lethargy. Two children
experienced recurrent chest infections, and one child had recurrent
episodes of intercurrent febrile illnesses. One child lost weight on
the diet, his weight for age dropped from the 50th to the 15th
centile as per the WHO Child Growth standards. Reasons for
discontinuation of the diet included lack of efﬁcacy in four
children, and development of recurrent chest infections in two
children. At the two week spot check test, 11 patients had
moderate and large urinary ketosis, while 4 children had small
(one), trace (one) or absent urinary ketones (two).
4. Discussion
Traditionally the modiﬁed Atkins diet has been considered for
use in older children, adolescents and adults as it is less restrictive
than ketogenic diet. However, the modiﬁed Atkins diet may offer
some beneﬁts over ketogenic diet even in young children. Apart
from outpatient initiation and ease of administration, children on
this diet may experience fewer growth problems as proteins are
not restricted. This diet is also ideal for resource-constraint
settings with paucity of trained dieticians.17 It does not require
strict weighing of foods and is thus easier for parents to administer.
The preponderance of males in our study possibly reﬂects the
gender bias for referral, in our society.
A 40% rate of spasm resolution at threemonths in our studywas
encouraging and comparable to the outcomes reported with KD.
Kossoff et al.6 reported spasm freedom in three out of 21 children
(14%), while Eun et al.7 reported spasm freedom in 15 out of 43
children (35%) at three months. In a large series of 104 children
with infantile spasms treated with the ketogenic diet, spasm
freedom was seen in 18% of the patients at 3 months and 28% at 6
months on the diet. These outcomes are better than those for
newer drugs such as topiramate (17%)2 and levetiracetam (11%).3
In our study the diet was well tolerated by young children.
Table 1
The experience of modiﬁed Atkins diet in 15 children with infantile spasms.
Patient
no./sex
Age (Mo) at
onset
Age (Mo) at
starting diet
Etiology Co-morbidities Drugs failed Outcome at three months Days from
initiation of
diet to spasm
cessation
Adverse events
1/M 5 12 Perinatal stroke GDD, CP ACTH, VGB, VPA, NTZ Spasm free 7 Nil
2/M 6 30 Perinatal Hypoxic Ischemic injury GDD, CP, VI VPA, VGB, NTZ, CLN Spasm free 3 Constipation
3/F 1.5 9 Cryptogenic GDD ACTH, VGB, VPA, TPM, Pyridoxine Approximately 25%
reduction in spasms
– Constipation
4/M 4 26 Perinatal Hypoxic Ischemic injury GDD, CP ACTH, VPA, CLB, Pred, LEV No reduction in spasms – Weight loss
5/M 2 6.5 Perinatal Hypoxic Ischemic injury GDD, CP, VI, HI ACTH, VGB, VPA, CLN No reduction in spasms – Lethargy, vomiting
6/M 1.5 20 Perinatal Hypoxic Ischemic injury GDD, CP, VI ACTH, VGB, TPM, VPA, Pred, CLB, NTZ No reduction in spasms – Lethargy, frequent
chest infections
7/M 4 21 Perinatal Hypoxic Ischemic injury GDD, CP, VI ACTH, VGB, TPM, VPA Spasm free 3 Constipation
8/M 9 30 Neonatal sepsis, meningitis GDD, CP VGB, CLN, VPA Spasm free 10 Nil
9/M 1 29 Bilateral open lip schizencephaly GDD, CP, VI, HI ACTH, VPA, VGB, TPM, CLN No spasms, 2–3 brief
myoclonic jerks/week
21 Constipation
10/M 5 28 Perinatal Hypoxic Ischemic injury GDD, CP, VI ACTH, VGB, VPA, NTZ, LEV 90% reduction in spasms – Constipation
11/M 5 21 Cryptogenic GDD ACTH, VPA, TPM, ZNS, CLB, Pyridoxine Spasm free 60 Constipation
12/F 5 36 Post-encephalitic sequelae GDD, CP ACTH, VGB, CLB, VPA 25% reduction in spasms – Lethargy
13/F 6 27 Perinatal Hypoxic Ischemic injury GDD, CP ACTH, Pred, CLN, VGB, TPM No reduction in spasms – Lethargy, frequent
intercurrent
febrile illness
14/M 4 24 Perinatal Hypoxic Ischemic injury GDD, CP, HI Pred,VPA, CLB 75% reduction in spasms – Lethargy, recurrent
chest infections
15/M 4 24 Neonatal hypoglycemia GDD, CP Pred, VGB, VPA, Spasm free 5 Nil
ACTH, adrenocorticotrophic hormone; CP, cerebral palsy; CLB, clobazam; CLN, clonazepam; F, female; GDD, global developmental delay; HI, hearing impairment; LEV, levetiracetam; M, male; NTZ, nitrazepam; Pred, prednisolone;
TPM, topiramate; VPA, valproate; VGB, vigabatrin; VI, vision impairment; ZNS, zonisamide.
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frequent chest infections in two children was possibly due to
exacerbation of underlying gastro-esophageal reﬂux. This has been
reported with the KD as well. Two children did not develop urinary
ketosis. The carbohydrate limit of 10 g/day was perhaps too high
for these children. Perhaps the fat content in the diet needs to be
increased along with a reduction in the carbohydrate limits in
young children who do not develop ketosis. Adherence to the diet
was not problematic, in patients in whom the spasms were
controlled. Two patients discontinued the diet because of adverse
effects. The results of our study need to be interpreted keeping in
mind the drawbacks of uncontrolled small sample studies. The
possibility of spontaneous resolution of spasms with time cannot
be excluded. The use of parental reporting of seizures as the
primary outcomemeasure also has inherent limitations. Long term
video-EEG documentation would have been ideal to assess
response. Despite these limitations we found the modiﬁed Atkins
diet to be a feasible, effective and well tolerated in children with
refractory infantile spasms. Further studies are needed to compare
the efﬁcacy of this therapy with other treatments such as the
ketogenic diet and newer anticonvulsants, and also as treatment
for new onset infantile spasms.
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